Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups
Diyaa H Bokhary1, Nidal H Bokhary1, Lamees E Seadawi1
1Emergency Medicine, King Abdulaziz University Hospital, Jeddah, SAU.
Insights
COVID-19 prevalence varied by ABO blood group, with group O most common and AB least common. However, no blood group showed worse COVID-19 severity or outcomes, indicating ABO type is not a major predictor of disease severity.
Area of Science:
- Infectious Diseases
- Hematology
- Epidemiology
Background:
- The relationship between ABO blood groups and coronavirus disease 2019 (COVID-19) outcomes remains an area of investigation.
- Understanding potential demographic predispositions to disease severity is crucial for public health strategies.
Purpose of the Study:
- To investigate if COVID-19 severity and patient outcomes differ across ABO blood groups.
- To identify any associations between ABO blood type and clinical characteristics, laboratory findings, or mortality in COVID-19 patients.
Main Methods:
- A retrospective study of 363 COVID-19 patients from March to June 2020 with recorded ABO blood types.
- Data collected included demographics, clinical features, vital signs, laboratory results, and COVID-19 outcomes.
- Multivariate logistic regression analysis was employed, adjusting for sociodemographic, clinical, and laboratory variables.
Main Results:
- Blood group O was most prevalent (38.8%), and AB was least prevalent (8.8%) among COVID-19 patients.
- Patients with blood group AB had fewer comorbidities (p = 0.007). C-reactive protein levels were associated with blood groups A, B, and O (p = 0.036).
- No statistically significant differences were observed in emergency department disposition, intensive care unit admission, mechanical ventilation, or hospital mortality among ABO blood groups.
Conclusions:
- While COVID-19 prevalence differs by ABO blood group, no specific blood group is associated with worse disease severity or outcomes.
- ABO blood grouping is not a significant predictor of COVID-19 severity or outcomes.
- Further research should focus on established risk factors for predicting COVID-19 severity and outcomes.
Abstract:
The primary objective of this study was to explore whether coronavirus disease 2019 (COVID-19) severity and outcomes varied between different ABO blood groups. This retrospective study included 363 COVID-19 confirmed patients who had their blood group recorded in the hospital medical records, from March to June 2020. Data representing demographics, clinical features, vital signs, laboratory findings, and COVID-19 outcomes were collected. Multivariate logistic regression was used for analysis and the results were adjusted for sociodemographic, clinical, and laboratory variables. The patients' mean age was 50 ± 17.8 years. Of the 363 patients, 30% were blood group A, 22.3% were blood group B, 8.8% were blood group AB, and 38.8% were blood group O. Bivariate analysis showed that patients with blood group AB were more likely to be free of any medical disease (65.6%) compared to other blood groups (p = 0.007). Fever was the most common presenting complaint (66.7%), and it did not significantly vary with changes in ABO blood groups (p = 0.230). Regarding laboratory characteristics, only C-reactive protein (CRP) levels were significantly associated with the blood groups, with high levels seen in blood groups A, B, and O (p = 0.036). In multivariate analysis, variations in emergency department (ED) disposition, requirement of intensive care unit care, and requirement of mechanical ventilation were not statistically significant among the different ABO blood groups. Furthermore, no correlation was found between hospital death and the different ABO blood groups. In conclusion, COVID-19 is most prevalent among patients with blood group O and least prevalent among those with blood group AB. No particular blood group had worse COVID-19 disease severity and outcomes than other blood groups. Therefore, we believe that ABO blood grouping should not be used as a major assessment tool for COVID-19 disease severity and outcome, and other known risk factors should be investigated.
More Related Videos
Related Concept Videos
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group


